Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Maura

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|September 17, 2011
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemiaGiuseppe Gritti, Gianluigi Reda, Francesco Maura, et al.
Haematologica|May 6, 2021
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcomeKatia Todoerti, Domenica Ronchetti, Vanessa Favasuli, et al.
Leukemia Research|January 25, 2023
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasmsJacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.
Blood Advances|November 7, 2025
Racial and Clinical Determinants of Response in 2,304 r/r BCL Treated with Anti-CD19 CAR T-Cells in Clinical TrialsSoon Jye Kho, Sheila S Diamond, Penelope Lafeuille, et al.
Leukemia|January 23, 2021
Positive selection as the unifying force for clonal evolution in multiple myelomaBenjamin Diamond, Venkata Yellapantula, Even H Rustad, et al.
American Journal of Hematology|June 22, 2012
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemiaGianluigi Reda, Francesco Maura, Giuseppe Gritti, et al.
Communications Biology|March 30, 2021
mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignanciesEven H Rustad, Ferran Nadeu, Nicos Angelopoulos, et al.
Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.
Nature Reviews. Urology|July 29, 2022
Mutagenic effect of chemotherapy on sperm DNA and implications for family planningAri P Bernstein, Justin Loloi, Rohit Reddy, et al.
Blood Cancer Journal|July 24, 2020
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessmentMalin Hultcrantz, Even Holth Rustad, Venkata Yellapantula, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|September 17, 2011
Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemiaGiuseppe Gritti, Gianluigi Reda, Francesco Maura, et al.
Haematologica|May 6, 2021
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcomeKatia Todoerti, Domenica Ronchetti, Vanessa Favasuli, et al.
Leukemia Research|January 25, 2023
Therapy-selected clonal hematopoiesis and its role in myeloid neoplasmsJacob Jahn, Benjamin Diamond, Jeffrey Hsu, et al.
Blood Advances|November 7, 2025
Racial and Clinical Determinants of Response in 2,304 r/r BCL Treated with Anti-CD19 CAR T-Cells in Clinical TrialsSoon Jye Kho, Sheila S Diamond, Penelope Lafeuille, et al.
Leukemia|January 23, 2021
Positive selection as the unifying force for clonal evolution in multiple myelomaBenjamin Diamond, Venkata Yellapantula, Even H Rustad, et al.
American Journal of Hematology|June 22, 2012
Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemiaGianluigi Reda, Francesco Maura, Giuseppe Gritti, et al.
Communications Biology|March 30, 2021
mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignanciesEven H Rustad, Ferran Nadeu, Nicos Angelopoulos, et al.
Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.
Nature Reviews. Urology|July 29, 2022
Mutagenic effect of chemotherapy on sperm DNA and implications for family planningAri P Bernstein, Justin Loloi, Rohit Reddy, et al.
Blood Cancer Journal|July 24, 2020
Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessmentMalin Hultcrantz, Even Holth Rustad, Venkata Yellapantula, et al.
Pageof 15